Grant: Project Grant - PA: Sex and Gender in Health Research (Bridge funding)
University of Guelph
$100,000.00
Modulating cocaine seeking by gonadal hormones in rats: sex differences in neural mechanisms of relapse-like behaviour
EF 2022-23
Résumé
Cocaine use disorder (CUD) affects millions of individuals and is associated with adverse biological and psychological states, so finding pharmacological targets for relapse prevention would improve the quality of life of many Canadians. Estrogen (E2) and progesterone (P4) are gonadal hormones found in both men and women. In rodent models, E2 increases relapse-related drug-seeking behaviours, and P4 inhibits them. Since these hormones interact with many proteins throughout the brain, including areas related to CUD, insights into the mechanisms of hormone modulation of relapse risk may bring about targets for the development of pharmacotherapies for CUD. In Aim 1, we will assess levels of neuronal activation in brain regions known to be involved in relapse in gonadectomized (GDX) rats treated or not treated with E2 or P4. We will also apply E2 or P4 to brain regions involved in relapse in rats undergoing relapse tests to assess the extent to which these regions mediate the effects of these hormones on relapse risk. In Aim 2, we will investigate the pharmacological mechanisms through which E2 increases and P4 decreases relapse risk. E2 and P4 interact to varying degrees with glutamate systems, growth factors, and estrogen and progesterone receptors. We will assess the extent of the involvement of these mechanisms by pretreating rats with E2 or P4 along with pharmacological activation or inhibition of these receptors during relapse tests. In Aim 3, we will assess interactions between glutamate systems and E2 or P4 by measuring levels of glutamate release as well as glutamatergic-specific proteins in brain regions known to be involved in relapse following a cocaine prime.
Programme
Project Grant - PA: Sex and Gender in Health Research (Bridge funding)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
473387
Name
Murray Jennifer E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Behavioural Sciences - A: Neurobiological Basis of Behavioural Processes
Projecttitle
Modulating cocaine seeking by gonadal hormones in rats: sex differences in neural mechanisms of relapse-like behaviour
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Sex and Gender in Health Research (Bridge funding)
Keyworddelim
Cocaine; Dopamine; Drug Seeking; Estrogen; Estrogen Receptor; Glutamate; Gonadal Hormones; Progesterone; Relapse; Sex Differences
Abstract
Cocaine use disorder (CUD) affects millions of individuals and is associated with adverse biological and psychological states, so finding pharmacological targets for relapse prevention would improve the quality of life of many Canadians. Estrogen (E2) and progesterone (P4) are gonadal hormones found in both men and women. In rodent models, E2 increases relapse-related drug-seeking behaviours, and P4 inhibits them. Since these hormones interact with many proteins throughout the brain, including areas related to CUD, insights into the mechanisms of hormone modulation of relapse risk may bring about targets for the development of pharmacotherapies for CUD. In Aim 1, we will assess levels of neuronal activation in brain regions known to be involved in relapse in gonadectomized (GDX) rats treated or not treated with E2 or P4. We will also apply E2 or P4 to brain regions involved in relapse in rats undergoing relapse tests to assess the extent to which these regions mediate the effects of these hormones on relapse risk. In Aim 2, we will investigate the pharmacological mechanisms through which E2 increases and P4 decreases relapse risk. E2 and P4 interact to varying degrees with glutamate systems, growth factors, and estrogen and progesterone receptors. We will assess the extent of the involvement of these mechanisms by pretreating rats with E2 or P4 along with pharmacological activation or inhibition of these receptors during relapse tests. In Aim 3, we will assess interactions between glutamate systems and E2 or P4 by measuring levels of glutamate release as well as glutamatergic-specific proteins in brain regions known to be involved in relapse following a cocaine prime.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Murray, Jennifer E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~